Abatacept for Crohn’s Disease and Ulcerative Colitis
A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn’s disease
Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis
Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn’s disease: a randomized controlled trial